|
ABCL
|
AbCellera Biologics Inc.
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ADIL
|
Adial Pharmaceuticals, Inc
|
US
|
NASDAQ
|
|
ALPN
|
Alpine Immune Sciences, Inc.
|
US
|
NASDAQ
|
|
ALZN
|
Alzamend Neuro, Inc.
|
US
|
NASDAQ
|
|
APTX
|
Aptinyx Inc.
|
US
|
NASDAQ
|
|
ARTL
|
Artelo Biosciences, Inc.
|
US
|
NASDAQ
|
|
ATAI
|
ATAI Life Sciences N.V.
|
US
|
NASDAQ
|
|
CALT
|
Calliditas Therapeutics AB
|
US
|
NASDAQ
|
|
CERT
|
Certara, Inc.
|
US
|
NASDAQ
|
|
CLNN
|
Clene Inc.
|
US
|
NASDAQ
|
|
CMND
|
Clearmind Medicine Inc.
|
US
|
NASDAQ
|
|
CPIX
|
Cumberland Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
CPRX
|
Catalyst Pharmaceutical Partners, Inc.
|
US
|
NASDAQ
|
|
CRXT
|
Clarus Therapeutics Holdings, Inc.
|
US
|
NASDAQ
|
|
CUE
|
Cue Biopharma, Inc.
|
US
|
NASDAQ
|
|
DYAI
|
Dyadic International, Inc.
|
US
|
NASDAQ
|
|
EDSA
|
Edesa Biotech, Inc.
|
US
|
NASDAQ
|
|
ELDN
|
Eledon Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
EVO
|
Evotec SE
|
US
|
NASDAQ
|